Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting

類似資料

• May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
  著者:: Scicali, Roberto, 等
  出版事項: (2020)
• Analysis of Arterial Stiffness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience
  著者:: Scicali, Roberto, 等
  出版事項: (2020)
• Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
  著者:: Scicali, Roberto, 等
  出版事項: (2019)
• PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
  著者:: Arianna Toscano, 等
  出版事項: (2022-04-01)
• Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
  著者:: Simona Marchisello, 等
  出版事項: (2019-04-01)